Editorial Board for section 'Cancer Therapy'
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada
Interests: signal transduction; cytoskeleton; cell migration; drug discovery; cancer
Interests: signal transduction; cytoskeleton; cell migration; drug discovery; cancer
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
Interests: partial breast irradiation; bladder preservation; multimodality treatment; anal carcinoma; chemoradiation; radiotherapy target delineation; hyperthermia
Interests: partial breast irradiation; bladder preservation; multimodality treatment; anal carcinoma; chemoradiation; radiotherapy target delineation; hyperthermia
Laboratory of Cell and Molecular Physiology, University of Picardie Jules Verne, Amiens, France
Interests: cancer research; cell signaling; ion channels; TRP channels; breast cancer cell
Interests: cancer research; cell signaling; ion channels; TRP channels; breast cancer cell
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, USA
Interests: chemical biology; epigenetics; drug design; fibrosis; RNA–small molecule interaction
Special Issues, Collections and Topics in MDPI journals
Interests: chemical biology; epigenetics; drug design; fibrosis; RNA–small molecule interaction
Special Issues, Collections and Topics in MDPI journals
Department of Nanomedicine, Methodist Neil Cancer Center and Houston Methodist Research Institute, Houston, TX 77030, USA
Interests: experimental; therapeutics; identification of novel molecular targets related to cell survival pathways, signaling pathways such as EF2-Kinase (EF2K), FOXM1, AXL, and KRAS signaling; RNA (siRNA, miRNA, lncRNA) therapeutics; nanotherapeutics/nanodelivery systems (lipid, polymer and metal-based); development of tumor targeted therapies, kinase inhibitors, immunotherapy; immunosuppressive tumor microenviorenment; tumor associated macrophages
Special Issues, Collections and Topics in MDPI journals
Interests: experimental; therapeutics; identification of novel molecular targets related to cell survival pathways, signaling pathways such as EF2-Kinase (EF2K), FOXM1, AXL, and KRAS signaling; RNA (siRNA, miRNA, lncRNA) therapeutics; nanotherapeutics/nanodelivery systems (lipid, polymer and metal-based); development of tumor targeted therapies, kinase inhibitors, immunotherapy; immunosuppressive tumor microenviorenment; tumor associated macrophages
Special Issues, Collections and Topics in MDPI journals
1. Biomedical Department, Centre Scientifique de Monaco, 98000 Monaco, Monaco
2. LIA ROPSE, Laboratoire International Associé Université Côte d’Azur—Centre Scientifique de Monaco, 06100 Nice, France
3. Institute for Research on Cancer and Aging of Nice (IRCAN), University Nice Cote d’Azur, CNRS UMR 7284, INSERM U1081, Centre Antoine Lacassagne, 06189 Nice, France
Interests: tumor signaling pathway
Special Issues, Collections and Topics in MDPI journals
Interests: tumor signaling pathway
Special Issues, Collections and Topics in MDPI journals
Department of Radiation Oncology, Duke University, Durham, NC, USA
Interests: optical imaging; optical spectroscopy; tumor hypoxia; radiation therapy; intravital microscopy; tumor physiology; angiogenesis; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: optical imaging; optical spectroscopy; tumor hypoxia; radiation therapy; intravital microscopy; tumor physiology; angiogenesis; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, NY 10065, USA
Interests: molecular imaging with PET/CT; PET/MR; theranostics; radiolabeled antibodies; pediatric malignancies; beta and alpha emitters for imaging and targeted cancer therapies
Interests: molecular imaging with PET/CT; PET/MR; theranostics; radiolabeled antibodies; pediatric malignancies; beta and alpha emitters for imaging and targeted cancer therapies
Department of Haematology, Athens Medical, Center-Psychikon Branch, 1 Andersen str, Psychikon, 11525 Athens, Greece
Interests: Neoplasias; Lymphomas; Leukemias
Interests: Neoplasias; Lymphomas; Leukemias
Professor and Dean, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
Interests: targeted drug delivery; nanoparticles; antibody-drug conjugates; controlled release; chemoprevention; immunotherapy; cancer vaccine
Special Issues, Collections and Topics in MDPI journals
Interests: targeted drug delivery; nanoparticles; antibody-drug conjugates; controlled release; chemoprevention; immunotherapy; cancer vaccine
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Christos Papadimitriou
Section Board Member
Second Department of Surgery, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece
Interests: early breast cancer; adjuvant chemotherapy; chemotherapy for metastatic breast cancer; clinical trials; mTOR inhibitors; CDK4/6 inhibitors; endocrine therapy
Special Issues, Collections and Topics in MDPI journals
Interests: early breast cancer; adjuvant chemotherapy; chemotherapy for metastatic breast cancer; clinical trials; mTOR inhibitors; CDK4/6 inhibitors; endocrine therapy
Special Issues, Collections and Topics in MDPI journals
Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, Rome, Italy
Interests: alternative splicing; RNA metabolism; cancer genomics; RNA binding proteins; ewing sarcoma
Special Issues, Collections and Topics in MDPI journals
Interests: alternative splicing; RNA metabolism; cancer genomics; RNA binding proteins; ewing sarcoma
Special Issues, Collections and Topics in MDPI journals
Wexner Medical Center, Department of Surgery, Ohio State University, Columbus, OH 43210, USA
Interests: liver; hepatitis; cancer therapy; hepatocellular carcinoma; oncology; surgery; cancer diagnostics; biliary tract diseases; surgical oncology; colorectal cancer
Special Issues, Collections and Topics in MDPI journals
Interests: liver; hepatitis; cancer therapy; hepatocellular carcinoma; oncology; surgery; cancer diagnostics; biliary tract diseases; surgical oncology; colorectal cancer
Special Issues, Collections and Topics in MDPI journals
School of Medicine, University of East Anglia, Norwich NR4 7TJ, UK
Interests: prostate cancer; breast cancer; cell biology; chemoresistance; targeted therapies; lipid signalling; sphingosine kinase; nanoparticles; drug delivery
Interests: prostate cancer; breast cancer; cell biology; chemoresistance; targeted therapies; lipid signalling; sphingosine kinase; nanoparticles; drug delivery
1. Leslie Diamond Chair in Cancer Survivorship, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada
3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada
Interests: health economics; cancer survivorship; health technology assessment; cost-effectiveness analysis; drug pricing drug reimbursement; public engagement
Special Issues, Collections and Topics in MDPI journals
2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada
3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada
Interests: health economics; cancer survivorship; health technology assessment; cost-effectiveness analysis; drug pricing drug reimbursement; public engagement
Special Issues, Collections and Topics in MDPI journals
Unit of Minimally Invasive Gastrontestinal Surgery, Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University Hospital “G.B. Rossi”, Piazzale L. Scuro, 10, 37134 Verona, Italy
Interests: colorectal cancer; cholangiocarcinoma; Colorectal signet ring cell carcinoma
Interests: colorectal cancer; cholangiocarcinoma; Colorectal signet ring cell carcinoma
1. Department of Pathology, University of Texas Southwestern Medical Center, 6201 Harry Hines Blvd, Dallas, TX 75235, USA
2. Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
Interests: breast cancer; triple-negative breast cancer; tumor biomarkers; therapeutic targets
2. Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
Interests: breast cancer; triple-negative breast cancer; tumor biomarkers; therapeutic targets
Department of Medical Oncology, University General Hospital of Ioannina, 45500 Ioannina, Greece
Interests: gastrointestinal cancer; cancer of unknown primary; liquid biopsies; drug development
Interests: gastrointestinal cancer; cancer of unknown primary; liquid biopsies; drug development
Brighton and Sussex Medical School, University of Sussex, Brighton BN19PX, UK
Interests: chronic lymphocytic leukaemia; drug resistance; BCL2 family; drug development; NF-KB; clonal evolution; telomere length
Interests: chronic lymphocytic leukaemia; drug resistance; BCL2 family; drug development; NF-KB; clonal evolution; telomere length
1. Institute of Dermatology, Università Cattolica, 00168 Rome, Italy
2. Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
Interests: skin cancer; melanoma
2. Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
Interests: skin cancer; melanoma
Department of Molecular Biology, Umeå University, Umeå, Sweden
Interests: KRAS mutations; cancer metastasis; treatment resistance; novel KRAS inhibitor
Special Issues, Collections and Topics in MDPI journals
Interests: KRAS mutations; cancer metastasis; treatment resistance; novel KRAS inhibitor
Special Issues, Collections and Topics in MDPI journals
1. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
2. Department of Biochemistry, Medical University of Gdansk, 80-210 Gdansk, Poland
Interests: cancer
Special Issues, Collections and Topics in MDPI journals
Interests: cancer
Special Issues, Collections and Topics in MDPI journals
Department of Otorhinolaryngology, Maxillofacial and Thyroid Surgery, Fondazione IRCCS, National Cancer Institute of Milan, Via Giacomo Venezian 1, 20133 Milan, Italy
Interests: head and neck surgery; radiotherapy; medical oncology
Special Issues, Collections and Topics in MDPI journals
Interests: head and neck surgery; radiotherapy; medical oncology
Special Issues, Collections and Topics in MDPI journals
Department of Radiation Oncology, MediClin Robert Janker Klinik, Villenstrasse 8, 53129 Bonn, Germany
Interests: radiotherapy; brachytherapy; prostate cancer; quality of life; hydrogel spacer
Interests: radiotherapy; brachytherapy; prostate cancer; quality of life; hydrogel spacer
Department of Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy
Interests: gastrointestinal tumors, mesothelioma, immunoncology, target therapies
Interests: gastrointestinal tumors, mesothelioma, immunoncology, target therapies
Biogem S.C.A.R.L., 83031 Ariano Irpino (AV), Italy
Interests: Cancer; Experimental therapeutics; DNA damaging agents; Angiogenesis; HDAC inhibitors; Epigenetics
Interests: Cancer; Experimental therapeutics; DNA damaging agents; Angiogenesis; HDAC inhibitors; Epigenetics
Cholesterol Metabolism and Therapeutic Innovations Team, UMR 1037 INSERM-Toulouse University, Toulouse, France
Interests: oncometabolism; cholesterol; oxysterol; tumor promoter; tumor suppressor; breast cancer; medicinal chemistry; pre-clinical development
Special Issues, Collections and Topics in MDPI journals
Interests: oncometabolism; cholesterol; oxysterol; tumor promoter; tumor suppressor; breast cancer; medicinal chemistry; pre-clinical development
Special Issues, Collections and Topics in MDPI journals
Division of Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA
Interests: cancer therapeutic approaches; hematology oncology; targeted therapies
Special Issues, Collections and Topics in MDPI journals
Interests: cancer therapeutic approaches; hematology oncology; targeted therapies
Special Issues, Collections and Topics in MDPI journals
Gynaecological Oncology, Candiolo Cancer Institute, FPO - IRCCS, 10060 Candiolo, Italy
Interests: breast cancer; ovarian cancer; cervical cancer; endometrial cancer; surgery
Interests: breast cancer; ovarian cancer; cervical cancer; endometrial cancer; surgery
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
Interests: radio-sensitivity; personalized medicine; head and cancer and immunotherapy
Interests: radio-sensitivity; personalized medicine; head and cancer and immunotherapy
